Reply to M. Lambertini et al

Affiliations

¹ Isabelle Demeestere, Research Laboratory on Human Reproduction, Université Libre de Bruxelles, Brussels, Belgium; Pauline Brice, St Louis Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France; Fedro A. Peccatori, European Institute of Oncology, Milan, Italy; Alain Kentos, Jolimont Hospital, Haine-Saint-Paul, Belgium; Jehan Dupuis, Henri Mondor Hospital, Paris, France; Pierre Zachee, Algemeen Ziekenhuis Stuivenberg, Antwerp, Belgium; Rene-Olivier Casasnovas, Centre Hospitalier Universitaire Dijon, Dijon, France; Eric Van Den Neste, Cliniques Universitaires Université Catholique de Louvain Saint-Luc, Brussels, Belgium; Julie Dechene, Research Laboratory on Human Reproduction, Université Libre de Bruxelles, Brussels, Belgium; Viviane De Maertelaer, Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire, Université Libre de Bruxelles, Belgium; Dominique Bron, J. Bordet Institute, Brussels, Belgium; and Yvon Englert, Research Laboratory on Human Reproduction, Université Libre de Bruxelles, and Erasme Hospital, Brussels, Belgium.

Comment

Isabelle Demeestere et al. J Clin Oncol. 2017 Mar.

. 2017 Mar;35(7):805-806.

doi: 10.1200/JCO.2016.70.6093. Epub 2016 Nov 28.

¹ Isabelle Demeestere, Research Laboratory on Human Reproduction, Université Libre de Bruxelles, Brussels, Belgium; Pauline Brice, St Louis Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France; Fedro A. Peccatori, European Institute of Oncology, Milan, Italy; Alain Kentos, Jolimont Hospital, Haine-Saint-Paul, Belgium; Jehan Dupuis, Henri Mondor Hospital, Paris, France; Pierre Zachee, Algemeen Ziekenhuis Stuivenberg, Antwerp, Belgium; Rene-Olivier Casasnovas, Centre Hospitalier Universitaire Dijon, Dijon, France; Eric Van Den Neste, Cliniques Universitaires Université Catholique de Louvain Saint-Luc, Brussels, Belgium; Julie Dechene, Research Laboratory on Human Reproduction, Université Libre de Bruxelles, Brussels, Belgium; Viviane De Maertelaer, Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire, Université Libre de Bruxelles, Belgium; Dominique Bron, J. Bordet Institute, Brussels, Belgium; and Yvon Englert, Research Laboratory on Human Reproduction, Université Libre de Bruxelles, and Erasme Hospital, Brussels, Belgium.

No abstract available

Comment on

No Evidence for the Benefit of Gonadotropin-Releasing Hormone Agonist in Preserving Ovarian Function and Fertility in Lymphoma Survivors Treated With Chemotherapy: Final Long-Term Report of a Prospective Randomized Trial.
Demeestere I, Brice P, Peccatori FA, Kentos A, Dupuis J, Zachee P, Casasnovas O, Van Den Neste E, Dechene J, De Maertelaer V, Bron D, Englert Y. Demeestere I, et al. J Clin Oncol. 2016 Aug 1;34(22):2568-74. doi: 10.1200/JCO.2015.65.8864. Epub 2016 May 23. J Clin Oncol. 2016. PMID: 27217453 Clinical Trial.
Debated Role of Ovarian Protection With Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Women With Cancer.
Lambertini M, Falcone T, Unger JM, Phillips KA, Del Mastro L, Moore HC. Lambertini M, et al. J Clin Oncol. 2017 Mar;35(7):804-805. doi: 10.1200/JCO.2016.69.2582. Epub 2016 Nov 28. J Clin Oncol. 2017. PMID: 27893335 No abstract available.